Lifeboat Foundation

NEW YORK—(BUSINESS WIRE)— Paige, a technology disruptor in healthcare, has joined forces with Microsoft in the fight against cancer, making headway in their collaboration to transform cancer diagnosis and patient care by building the world’s largest image-based artificial intelligence (AI) models for digital pathology and oncology.

“Unleashing the power of AI is a game changer in advancing healthcare to improve lives.” Tweet this

Paige, a global leader in end-to-end digital pathology solutions and clinical AI, developed the first Large Foundation Model using over one billion images from half a million pathology slides across multiple cancer types. Paige is developing with Microsoft a new AI model that is orders-of-magnitude larger than any other image-based AI model existing today, configured with billions of parameters. This model assists in capturing the subtle complexities of cancer and serves as the cornerstone for the next generation of clinical applications and computational biomarkers that push the boundaries of oncology and pathology.

Which is a response to hypoxia typically coordinated by hypoxia-inducible transcription factors (HIFs); but growing evidence indicate that transcriptional programs beyond HIFs control tumor angiogenesis. Here we show that the redox-sensitive transcription factor BTB and CNC homology 1 (BACH1) controls the transcription of a broad range of angiogenesis genes. BACH1 is stabilized by lowering reactive oxygen species levels; consequently, angiogenesis gene expression in lung cancer cells, tumor organoids, and xenograft tumors increased substantially following vitamin C and E and N-acetylcysteine administration in a BACH1-dependent fashion under normoxia. Moreover, angiogenesis gene expression increased in endogenous BACH1–overexpressing cells and decreased in BACH1-knockouts in the absence of antioxidants.

What do you think? China is doing it. The West is going to have to keep up. Have you seen the Netflix series Altered Carbon? It’s like that.

A U.S. Army video shows its concept of the soldier of the future. At first glance, it looks like it will only be a better-equipped soldier.

Continue reading “U.S. Cyborg Soldiers to Confront China’s Enhanced ‘Super Soldiers’ — Is This the Future of Military?” »

Citizen Lab says two zero-days fixed by Apple today in emergency security updates were actively abused as part of a zero-click exploit chain (dubbed BLASTPASS) to deploy NSO Group’s Pegasus commercial spyware onto fully patched iPhones.

The two bugs, tracked as CVE-2023–41064 and CVE-2023–41061, allowed the attackers to infect a fully-patched iPhone running iOS 16.6 and belonging to a Washington DC-based civil society organization via PassKit attachments containing malicious images.

“We refer to the exploit chain as BLASTPASS. The exploit chain was capable of compromising iPhones running the latest version of iOS (16.6) without any interaction from the victim,” Citizen Lab said.

ROCHESTER, Minn. — In a randomized trial, published in The Lancet Oncology, Mayo Clinic Comprehensive Cancer Center researchers uncover evidence supporting a shorter treatment time for breast cancer patients. The study compared two separate dosing schedules of pencil-beam scanning proton therapy, the most advanced type of proton therapy known for its precision in targeting cancer cells while preserving healthy tissue to reduce the risk of side effects.

Survival rates for breast cancer continue to improve due to advances in diagnosis and treatment, leading to increasing emphasis on reducing the long-term toxicity of cancer treatment, including radiotherapy.

Prior to this study, all patients treated with proton postmastectomy radiotherapy (PMRT) had received a conventional 25-to 30-day course delivered five days per week over five to six weeks. The researchers hoped to demonstrate that condensing the course of proton beam therapy, a form of particle therapy that could spare the heart and lungs from radiation damage, may result in a similar side effect profile.

In just two weeks, the Indian mission has made some surprising discoveries about the composition of the Moon.

Appearing as a weird line of moving dots, SpaceX satellites can be seen training across the night sky and are often confused for UFOs.

Scientists hope to use the pilot technology to build out a more robust system that would produce enough oxygen for humans and for rocket propellant.

Aditya-L1, India’s solar probe, has snapped some striking shots in space, capturing itself and the Earth and moon.